Helmholtz Zentrum Fur Infektionsforschung identifies new argyrin derivatives
Jan. 26, 2026
Helmholtz Zentrum Fur Infektionsforschung GmbH has reported argyrin derivatives designed for potential use for the treatment of Neisseria gonorrhoeae and Clostridioides difficile infections.